← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 11, 2021Last known activity
Oct 31, 2023
Timeline
2010s
- Jun 1, 2018
Transcenta Therapeutics— Founded
Drugs by trial phase (8 distinct, 3 trials)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Recent trials (4)
- NCT06093425Lead sponsorPhase 3Oct 31, 2023
- NCT05731271Lead sponsorPhase 1/Phase 2Feb 8, 2023
- NCT04958434Study directorPhase 1Jun 11, 2021
- NCT04958434Lead sponsorPhase 1Jun 11, 2021
Details
- Founded
- Shanghai, CN Jun 1, 2018
- Last known activity
- Oct 31, 2023